Goich Kenneth, Pastore Dakota, Koutsenko Bianna, Infosino Benjamin, Sgrignoli Mitchell N, Schachter Todd
Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, USA.
Family Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, USA.
Cureus. 2024 Aug 11;16(8):e66630. doi: 10.7759/cureus.66630. eCollection 2024 Aug.
Shivering is a frequently encountered perioperative complication in patients undergoing spinal anesthesia. Numerous different pharmacological agents have been employed to mitigate this issue. This scoping review aims to evaluate the efficacy of ketamine in mitigating the incidence of shivering. This review process utilized PubMed, JAMA, and Cochrane as primary databases. Searches were performed using combinations of key terms: "Ketamine," "Shivering," "Spinal Anesthesia," and "Hypothermia." Reviews of reference lists for additional pertinent data were performed. When ketamine was compared against a saline control, three out of five studies found ketamine to be more effective (p < 0.05, p < 0.001, p < 0.001) in the prevention of shivering. When compared with tramadol, two studies found ketamine to be more effective (p < 0.001, p < 0.001), one found no difference (p = 0.261), and one found tramadol to be more effective (p < 0.001). Two studies found dexmedetomidine more effective (p < 0.022, p < 0.027) than ketamine and tramadol. When comparing ketamine, ondansetron, and meperidine, all three were effective (p < 0.001) versus saline, with no significant difference between the three. Meperidine demonstrated more efficacy (p < 0.05) in reducing the intensity of shivering than ketamine. Ketamine's effects on hemodynamics were shown to be equivocal or more favorable across several studies. While there is mixed evidence on whether it is better than other treatments, ketamine may have advantages from a hemodynamic standpoint. Dosages of 0.2-0.5 mg/kg with or without a subsequent infusion of 0.1 mg/kg per hour may aid in the prevention of perioperative shivering. Overall, ketamine is a safe and effective drug for the prevention of perioperative shivering. However, other drugs may be equally or more effective; therefore, patient population, hemodynamic status, patient preferences, and provider familiarity with different agents should be considered.
寒战是接受脊髓麻醉的患者围手术期常见的并发症。人们已使用多种不同的药物来缓解这一问题。本综述旨在评估氯胺酮在降低寒战发生率方面的疗效。本综述过程以PubMed、《美国医学会杂志》(JAMA)和考克兰系统评价数据库作为主要数据库。使用关键词组合进行检索:“氯胺酮”、“寒战”、“脊髓麻醉”和“体温过低”。还对参考文献列表进行了检索以获取更多相关数据。当将氯胺酮与生理盐水对照进行比较时,五项研究中有三项发现氯胺酮在预防寒战方面更有效(p < 0.05、p < 0.001、p < 0.001)。与曲马多相比,两项研究发现氯胺酮更有效(p < 0.001、p < 0.001),一项研究发现无差异(p = 0.261),还有一项研究发现曲马多更有效(p < 0.001)。两项研究发现右美托咪定比氯胺酮和曲马多更有效(p < 0.022、p < 0.027)。当比较氯胺酮、昂丹司琼和哌替啶时,三者与生理盐水相比均有效(p < 0.001),且三者之间无显著差异。哌替啶在减轻寒战强度方面比氯胺酮更有效(p < 0.05)。在多项研究中,氯胺酮对血流动力学影响表现为不明确或更有利。虽然关于氯胺酮是否优于其他治疗方法的证据不一,但从血流动力学角度来看,氯胺酮可能具有优势。0.2 - 0.5毫克/千克的剂量,无论是否随后每小时输注0.1毫克/千克,可能有助于预防围手术期寒战。总体而言,氯胺酮是预防围手术期寒战的一种安全有效的药物。然而,其他药物可能同样有效或更有效;因此,应考虑患者人群、血流动力学状态、患者偏好以及医疗人员对不同药物的熟悉程度。